Top broker says these ASX 200 stocks are buys following the market selloff

Let's see what the broker is recommending following recent weakness.

| More on:
ASX shares Business man marking buy on board and underlining it

Image Source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Now could be an opportune time to load up on some quality ASX 200 stocks according to one top broker.

According to a note out of Wilsons, its analysts believe that the recent market selloff has created an attractive risk/reward for Australian investors.

So, if you can stomach some volatility, then the stocks in this article could be worth considering. It said:

Following the pullback, the risk/reward of the ASX 200 has become increasingly attractive, with valuations now broadly in line with the historical average. However, we expect volatility to remain elevated over the near-term, with the prospect of tariffs remaining a market overhang until at least 2 April, when the US Department of Commerce is scheduled to release its comprehensive trade review.

Wilsons has highlighted a number of stocks to buy that feature in its Focus Portfolio. Let's see what they are:

Goodman Group (ASX: GMG)

This integrated industrial property giant could be an ASX 200 stock to buy according to the broker.

It highlights that its shares have pulled back meaningfully following a capital raising and the market selloff. Given its positive earnings outlook, it feels this has presented an opportunity for investors. It said:

GMG has pulled back largely due to last month's ~$4.4n capital raise to fund its data centre strategy. Notwithstanding the near-term equity dilution from the raise, GMG's EPS growth outlook remains attractive, underpinned by its data centre pipeline which will benefit from strong sector tailwinds from cloud migration and AI. We expect GMG to fund future developments with recycled capital (existing liquidity, retained earnings, equity sell-downs) and a modest amount of leverage

ResMed Inc. (ASX: RMD)

Another ASX 200 stock to get the thumbs up from Wilsons is sleep disorder treatment company ResMed.

It highlights that its shares have pulled back despite its strong second quarter update. The broker explains:

RMD has pulled back despite its strong Q2 EPS beat which drove consensus EPS upgrades. In the result management pointed to strong fundamentals as it highlighted 'once in a generation' tailwinds supporting CPAP demand over the medium-term (wearables, GLPs). At a PE of ~22x, RMD trades on a ~30% discount to its five-year average, which represents attractive value considering double-digit consensus EPS growth over the medium-term.

WiseTech Global Ltd (ASX: WTC)

Finally, this logistics solutions technology company could be cheap by historical standards according to the broker.

Commenting on the ASX 200 stock's significant decline, Wilsons said:

At a PE of ~60x, WTC trades at its lowest PE multiple in ~two years, offering highly attractive value on a growth-adjusted basis (3yr PEG of ~1.7x). WTC has pulled back following slight delays to the launch of Container Transport Optimisation (CTO). Despite the near-term downgrades, the medium/long-term earnings growth trajectory is broadly unchanged and remains attractive. WTC's 3 year EPS CAGR of >30% will be underpinned by 1) new customer wins, 2) large freight forwarder rollouts, and 3) the rollout of CTO (set to be launched initially in Australia in 2H25).

Should you invest $1,000 in Goodman Group right now?

Before you buy Goodman Group shares, consider this:

Motley Fool investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now... and Goodman Group wasn't one of them.

The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

And right now, Scott thinks there are 5 stocks that may be better buys...

See The 5 Stocks *Returns as of 6 March 2025

Motley Fool contributor James Mickleboro has positions in Goodman Group, ResMed, and WiseTech Global. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Goodman Group, ResMed, and WiseTech Global. The Motley Fool Australia has positions in and has recommended ResMed and WiseTech Global. The Motley Fool Australia has recommended Goodman Group. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Broker Notes

Smiling man sits in front of a graph on computer while using his mobile phone.
Broker Notes

Top brokers name 3 ASX shares to buy today

Here's what brokers are recommending as buys this week.

Read more »

A woman wine tasting in a bottle shop.
Value Investing

ASX value shares rated as broker buys

The sell-off has opened the window for value plays to shine.

Read more »

A woman relaxes on a yellow couch with a book and cuppa, and looks pensively away as she contemplates the joy of earning passive income.
Broker Notes

Lovisa shares down more than 30% from all-time high. Time to snap them up?

Analysts have given their verdict on this popular stock. Here's what they are saying.

Read more »

Business people discussing project on digital tablet.
Broker Notes

Brickworks shares down 25% in 1 year. Is this a buying opportunity?

Is this blue chip a bargain buy? Let's see what one leading broker thinks.

Read more »

Contented looking man leans back in his chair at his desk and smiles.
Broker Notes

Leading brokers name 3 ASX shares to buy today

Here's why brokers believe that now could be the time to snap up these shares.

Read more »

Overjoyed man celebrating success with yes gesture after getting some good news on mobile.
Broker Notes

These ASX 200 stocks could rise 25% to 40% after the market selloff

Analysts believe these shares have the potential to generate big returns over the next 12 months.

Read more »

Broker Notes

Top brokers name 3 ASX shares to buy next week

Brokers gave buy ratings to these ASX shares last week. Why are they bullish?

Read more »

Shot of a scientist using a computer while conducting research in a laboratory.
Healthcare Shares

Should you buy the dip on the CSL share price?

Has the market sell-off created an opportunity to buy this mega ASX 200 blue chip at an attractive price?

Read more »